Brief: Prenetics Announces Third Quarter 2023 Financial Results
20/11/2023 11:47
Nov 20 (Reuters) - Prenetics Global Ltd PRE.O :
* PRENETICS ANNOUNCES THIRD QUARTER 2023 FINANCIAL RESULTS
* PRENETICS GLOBAL: COST REDUCTION & RESTRUCTURING
PROGRESSED AS
PLANNED; CIRCLEDNA, ACT GENOMICS EXPECTED TO ACHIEVE EBITDA
BREAKEVEN BY END OF YEAR
* PRENETICS GLOBAL LTD: QTRLY LOSS PER SHARE $0.08
* PRENETICS GLOBAL LTD: QTRLY LOSS PER SHARE - CONTINUING
OPERATIONS $0.07
* PRENETICS GLOBAL LTD: CASH AND OTHER SHORT-TERM ASSETS OF
$105.2
MILLION AS OF SEPTEMBER 30, 2023
Source text for Eikon: ID:nGNXTwbzD
Further company coverage: PRE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prenetics Global
See all newsBrief: Prenetics’ Im8 Announces Two-Time Golden Globe-Nominated Actress And Producer Lily Collins As Im8 Global Ambassador And Shareholder In Multi-Year Partnership
U.S. STOCKS ON THE MOVE-Gold miners, Weave Communications, Amylyx Pharmaceuticals
U.S. STOCKS ON THE MOVE-BioMarin Pharmaceutical, Home Depot, Klarna Group
Prenetics Global Ltd reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-EyePoint Inc, Amer Sports, Pliant Therapeutics